An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.

The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.

Read the full article

References

Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).

Share this

Related Posts

Allergies in U.S. Adults

Functional Difficulties in Children

Why Looking at the Sky Can Make You Dizzy: Understanding BPPV

Recent Posts

River Center Shopping Mall in the event. The vessel of the Fiesta Children

The Perfect Blend of Professional and Personal

AAA 2026 is coming to San Antonio—right in the middle of Fiesta, one of the city’s most vibrant celebrations. This year, it’s easier than ever…

Read More
The Centers for Medicare and Medicaid Services (CMS) webpage. CMS is a federal agency within the United States Department of Health and Human Services HHS.

CMS Sets Medically Unlikely Edit for Key Audiology Codes

The Centers for Medicare and Medicaid Services (CMS) has established a Medically Unlikely Edit (MUE) of two units per date of service for Current Procedural Terminology (CPT®) codes 92629, 92632,…

Read More
Young African-American woman with tissue and nasal spray suffering from allergy on light blue background with space for text

Allergies in U.S. Adults

Individuals who live in colder areas of the country may be eagerly awaiting the arrival of spring and its associated warmer weather. Others may be…

Read More